1. World Health Organization (WHO). Campylobacter. https://www.who.int/news-room/fact-sheets/detail/campylobacter (Erişim tarihi: 02.02.2024).
2. European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC). The European Union One Health 2022 Zoonoses Report.
3. Delahoy MJ, Shah HJ, Weller DL, et al. Preliminary incidence and trends of infections caused by pathogens transmitted commonly through food — Foodborne Diseases Active Surveillance
Network, 10 U.S. Sites, 2022. MMWR Morb Mortal Wkly Rep 2023; 72: 701-706.
4. Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev 2015; 28(3): 687-720.
5. Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect 2004; 10(10): 868-876.
6. Moore JE, Corcoran D, Dooley JSG, et al. Campylobacter. Vet Res 2005; 36: 351-382.
7. Kreling V, Falcone FH, Kehrenberg C, Hensel A. Campylobacter sp.: Pathogenicity factors and prevention methods-new molecular targets for innovative antivirulence drugs? Appl Microbiol
Biotechnol 2020; 104(24): 10409-10436.
8. Dekeyser P, Gossuin-Detrain M, Butzler JP, Sternon J. Acute enteritis due to a related vibrio: first positive stool cultures. J Infect Dis 1972; 125(4): 390-392.
9. Skirrow MB. Campylobacter enteritis: a “new” disease. BMJ 1977; 2: 9–11.
10. Oren A, Garrity GM. Valid publication of the names of forty-two phyla. Int J Syst Evol Microbiol 2021; 71: 005056.
11. List of Prokaryotic names with Standing in Nomenclature. Genus: Campylobacter. https://lpsn.dsmz.de/genus/campylobacter (Erişim tarihi: 01.03.2024)
12. Vandamme P, Dewhirst FE, Paster BJ, On SLW. Campylobacter. In: Whitman WB, Rainey F, Kampfer P, Trujillo M, et al, eds. Bergey’s Manual of Systematics of Archaea and Bacteria. New
York, John Wiley & Sons Inc., Bergey’s Manual Trust; 2015. doi: 10.1002/9781118960608.gbm01071.
13. Costa D, Iraola G. Pathogenomics of emerging Campylobacter species. Clin Microbiol Rev 2019; 32(4): e00072-18.
14. Liu F, Lee SA, Xue J, Riordan SM, Zhang L. Global epidemiology of campylobacteriosis and the impact of COVID-19. Front Cell Infect Microbiol 2022; 12: 979055.
15. Fitzgerald C, Pruckler J, Karlsson M, Kwan P. The genus Campylobacter In: Goldman E, Green LH, eds. Practical Handbook of Microbiology. 3nd edition. Boca Raton-Florida, CRC Press;
2015.
16. Hameed A, Woodacre A, Machado LR, Marsden GL. An updated classification system and review of the lipooligosaccharide biosynthesis gene locus in Campylobacter jejuni. Front Microbiol
2020; 11: 677.
17. Hansson I, Sandberg M, Habib I, Lowman R, Engvall EO. Knowledge gaps in control of Campylobacter for prevention of campylobacteriosis. Transbound Emerg Dis 2018; 65 (Suppl 1): 30-48.
18. Josko DA. Vibrio, Aeromonas, Campylobacter, Campylobacter like species. In: Mahon CR, Lehman DC, eds. Textbook of Diagnostic Micobiology. 7th edition. St Luis MO, Elsevier; 2023.
19. Havelaar AH, Kirk MD, Torgerson PR, et al. World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med 2015; 12(12):
e1001923.
20. Allos BM, Blaser MJ, Iovine NM, Kirkpatrick BD. Campylobacter jejuni and related species. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of
Infectious Diseases. 9th edition. Philadelphia, Elsevier; 2020.
21. European Centre for Disease Prevention and Control (ECDC). Campylobacteriosis. In: ECDC. Annual Epidemiological Report for 2022. Stockholm: ECDC; 2024.
22. Platts-Mills JA, Babji S, Bodhidatta L, et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health 2015;
3: e564–75.
23. Janssen R, Krogfelt KA, Cawthraw SA, et al. Host-pathogen interactions in Campylobacter infections: The host perspective. Clin Microbiol Rev 2008; 21(3): 505-18.
24. İlktac M, Öngen B. Campylobacter enfeksiyonlarında patogenez. İçinde: Badur S, Abacıoğlu H, Öngen B, eds. Enfeksiyon Patogenezi ve Bağışıklık. İstanbul, Akademi Yayınevi; 2015.
25. Heimesaat MM, Backert S, Alter T, Bereswill S. Molecular targets in Campylobacter infections. Biomolecules 2023; 13(3): 409.
26. Elmi A, Nasher F, Dorrell N, Wren B, Gundogdu O. Revisiting Campylobacter jejuni virulence and fitness factors: Role in sensing, adapting, and competing. Front Cell Infect Microbiol 2021;
10: 607704.
27. Kemper L, Hensel A. Campylobacter jejuni: targeting host cells, adhesion, invasion, and survival. Appl Microbiol Biotechnol 2023; 107(9): 2725-2754.
28. Backert S, Tegtmeyer N, Cróinín TÓ, Boehm M, Heimesaat MM. Human campylobacteriosis. In: Klein G, ed. Campylobacter Features, Detection, and Prevention of Foodborne Disease.
London, Academic Press; 2017.
29. Wagenaar JA, van Bergen MA, Blaser MJ, Tauxe RV, Newell DG, van Putten JP. Campylobacter fetus infections in humans: exposure and disease. Clin Infect Dis 2014; 58(11): 1579-1586.
30. Liu F, Ma R, Wang Y, Zhang L. The clinical importance of Campylobacter concisus and other human hosted Campylobacter species. Front Cell Infect Microbiol 2018; 8: 243.
31. Yi J, Anderson EJ. Campylobacter jejuni and Campylobacter coli. In: Long SS, Prober CG, Fischer M, Kimberlin DW, eds. Principles and Practice of Pediatric Infectious Diseases. 6th edition.
Philadelphia, Elsevier; 2023.
32. Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011; 8(12): 669-685.
33. Whitehouse CA, Zhao S, Tate H. Antimicrobial resistance in Campylobacter species: Mechanisms and genomic epidemiology. Adv Appl Microbiol 2018; 103: 1-47.
34. Awofisayo-Okuyelu A, Hall I, Adak G, Hawker JI, Abbott S, McCarthy N. A systematic review and meta-analysis on the incubation period of campylobacteriosis. Epidemiol Infect 2017;
145(11): 2241-2253.
35. Teksoy N, İlktaç M, Öngen B. Investigating the significance of non-jejuni/coli Campylobacter strains in patients with diarrhea. Healthcare (Basel) 2023; 11(18): 2562.
36. Same RG, Tamma PD. Campylobacter infections in children. Pediatr Rev 2018; 39(11): 533-541.
37. Schiaffino F, Kosek MN. Intestinal and extra-intestinal manifestations of Campylobacter in the immunocompromised host. Curr Treat Options Infect Dis 2020; 12: 361-374.
38. Ongen B, Kucukkaya IC, Karapinar BA, Ilktac M. Recurrent Campylobacter jejuni enteritis in a patient with common variable immunodeficiency over an eight year period. Clin Lab 2023;
69(9).
39. Najjar I, Paluca F, Loukidis K, Tarr PE. Recurrent Campylobacter enteritis in patients with hypogammaglobulinemia: Review of the literature. J Clin Med 2020; 9(2): 553.
40. Tinévez C, Velardo F, Ranc AG, et al. Retrospective multicentric study on Campylobacter spp. bacteremia in France: The Campylobacteremia Study. Clin Infect Dis 2022; 75(4): 702-709.
41. Otsuka Y, Hagiya H, Takahashi M, et al. Clinical characteristics of Campylobacter bacteremia: a multicenter retrospective study. Sci Rep 2023; 13(1): 647.
42. Schorling E, Knorr S, Lick S, Steinberg P, Brüggemann DA. Probability of sequelae following Campylobacter spp. infections: Update of systematic reviews and meta-analyses. Public Health
Chall 2023; 2: e145.
43. Takakura W, Kudaravalli P, Chatterjee C, Pimentel M, Riddle MS. Campylobacter infection and the link with irritable bowel syndrome: on the pathway towards a causal association. Pathog
Dis 2022; 80(1): ftac003.
44. Zayet S, Klopfenstein T, Gendrin V, et al. Campylobacter fetus invasive infections and risks for death, France, 2000-2021. Emerg Infect Dis 2023; 29(11): 2189-2197.
45. Seong YJ, Lee SH, Kim EJ, et al. Campylobacter fetus subspecies venerealis meningitis associated with a companion dog in a young adult: a case report. BMC Infect Dis 2021; 21(1): 1280.
46. Liu Y, Yamazaki W, Huang Y, Liao C, Sheng W, Hsueh P. Clinical and microbiological characteristics of patients with bacteremia caused by Campylobacter species with an emphasis on the
subspecies of C. fetus. J Microbiol Immunol Infect 2019; 52(1): 122-131.
47. Patrick ME, Gilbert MJ, Blaser MJ, Tauxe RV, Wagenaar JA, Fitzgerald C. Human infections with new subspecies of Campylobacter fetus. Emerg Infect Dis 2013; 19(10): 1678-1680.
48. Tilmanne A, Martiny D, Hallin M, et al. Campylobacter concisus and acute gastroenteritis in children: Lack of association. Pediatr Infect Dis J 2018; 37(12): e339-e341.
49. Liu F, Ma R, Tay CYA, et al. Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn’s disease. Emerg Microbes
Infect 2018; 7(1): 64.
50. Culture for Campylobacter and related organisms. In: Leber AL, Burnham CD, eds. Clinical Microbiology Procedures Handbook. 5th edition. Washington D.C., ASM Press; 2023.
51. Levican A, Hinton Jr A. CAMPYAIR, a new selective, differential medium for Campylobacter spp. isolation without the need for microaerobic atmosphere. Microorganisms 2022; 10(7): 1403.
52. Metreveli M, Bulia S, Shalamberidze I, et al. Campylobacteriosis, shigellosis and salmonellosis in hospitalized children with acute inflammatory diarrhea in Georgia. Pathogens 2022; 11(2):
232.
53. Ilktac M, Ongen B. Molecular typing of Campylobacter jejuni and Campylobacter coli of human strains isolated in Turkey over an eight-year period. Clin Lab 2020; 66(3).
54. Nielsen HL, Mølvadgaard M, Nielsen H, Kostrzewa M. Identification and differentiation of highly diverse Campylobacter concisus strains using the MALDI Biotyper. Clin Microbial 2016; 5(1):
1000230.
55. Martiny D, Dediste A, Debruyne L, et al. Accuracy of the API Campy system, the Vitek 2 Neisseria–Haemophilus card and matrix-assisted laser desorption ionization time-of-flight mass
spectrometry for the identification of Campylobacter and related organisms. Clin Microbiol Infect 2011; 17(7): 1001-1006.
56. Ray LC, Griffin PM, Wymore K, et al. Changing diagnostic testing practices for foodborne pathogens, Foodborne Diseases Active Surveillance Network, 2012–2019. Open Forum Infect Dis.
2022; 9(8): ofac344.
57. Fitzgerald C, Patrick M, Gonzalez A, et al. Multicenter evaluation of clinical diagnostic methods for detection and isolation of Campylobacter spp. from stool. J Clin Microbiol. 2016; 54(5):
1209-1215.
58. İlktaç M, Ongen B. Gıda kaynaklı enfeksiyonların tanısı ve kontrolünde moleküler yöntemlerin kullanımı. İçinde: Durmaz R, Eser Ö, Otlu B, editörler. Moleküler Mikrobiyoloji Tanı ve Epi-
demiyoloji. Ankara, Akademisyen Kitabevi; 2022.
59. Torres-Miranda D, Akselrod H, Karsner R, et al. Use of BioFire FilmArray gastrointestinal PCR panel associated with reductions in antibiotic use, time to optimal antibiotics, and length of
stay. BMC Gastroenterol 2020; 20(1): 246.
60. Freeman K, Tsertsvadze A, Taylor-Phillips, et al. Agreement between gastrointestinal panel testing and standard microbiology methods for detecting pathogens in suspected infectious gast-
roenteritis: Test evaluation and meta-analysis in the absence of a reference standard. PLoS One 2017; 12(3): e0173196.
61. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. CID 2017; 65(12):
e45–e80.
62. Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. Am J Gastroenterol 2016; 111: 602–622. (ACG
2016)
63. Kim YJ, Park K, Park D, et al. Guideline for the antibiotic use in acute gastroenteritis. Infect Chemother 2019; 51(2): 217-243.
64. Aguilar-Company J, Los-Arcos I, Pigrau C, et al. Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis. Antimicrob Agents Chemother 2016;
60(7): 4398-400.
65. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Expected resistant phenotypes. Version 1.2 January 2023. https://www.eucast.org/fileadmin/src/media/PDFs/EU-
CAST_files/Expert_Rules/2023/Expected_Resistant_Phenotypes_v1.2_20230113.pdf (Erişim tarihi: 04.03.2024).
66. Shen Z, Wang Y, Zhang Q, Shen J. Antimicrobial resistance in Campylobacter spp. Microbiol Spectr. 2018; 6(2).
67. ECDC, EFSA and EMA (European Centre for Disease Prevention and Control, European Food Safety Authority and European Medicines Agency). Antimicrobial consumption and resistance
in bacteria from humans and food-producing animals. EFSA Journal 2024; 22(2): e8589. https://doi.org/10.2903/j.efsa.2024.8589
68. EFSA (European Food Safety Authority) & ECDC (European Centre for Disease Prevention and Control). The European Union summary report on antimicrobial resistance in zoonotic and
indicator bacteria from humans, animals and food in 2021–2022. EFSA Journal 2024; 22(2): e8583. https://doi.org/10.2903/j.efsa.2024.8583.
69. Ongen B, Nazik H, Kaya I. Rutin dışkı kültürlerinde üretilen Campylobacter türleri ve antibiyotik duyarlılıkları: 5 yıllık sonuçların değerlendirilmesi. ANKEM Derg 2007; 21(1): 37-41.
70. Ilktac M, Ongen B, Humphrey TJ, Williams LK. Molecular and phenotypical investigation of ciprofloxacin resistance among Campylobacter jejuni strains of human origin: High prevalence of
resistance in Turkey. APMIS 2020; 128 (1): 41-47.
71. Abay S, Kayman T, Otlu B, Hizlisoy H, Aydin F, Ertas N. Genetic diversity and antibiotic resistance profiles of Campylobacter jejuni isolates from poultry and humans in Turkey. Int J Food
Microbiol 2014; 178: 29-38.
72. Kayman T, Abay S, Aydin F, Şahin O. Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. J Med Microbiol 2019; 68(2): 136-142.
73. Oncel B, Hasdemir U, Aksu B, Pournaras S. Antibiotic resistance in Campylobacter jejuni and Campylobacter coli: Significant contribution of an RND type efflux pump in erythromycin resis-
tance. J Chemother 2024; 36(2): 110-118.
74. Ford L, Healy JM, Cui Z, et al. Epidemiology and antimicrobial resistance of Campylobacter infections in the United States, 2005-2018. Open Forum Infect Dis 2023; 10(8): ofad378.
75. Hlashwayo DF, Sigaúque B, Noormahomed EV, et al. A systematic review and meta-analysis reveal that Campylobacter spp. and antibiotic resistance are widespread in humans in sub-Saharan
Africa. PLoS One 2021; 16(1): e0245951.
76. Paintsil EK, Ofori LA, Adobea S, et al. Prevalence and antibiotic resistance in Campylobacter spp. isolated from humans and food-producing animals in West Africa: A systematic review and
meta-analysis. Pathogens 2022; 11(2): 140.
77. Jafari S, Ebrahimi M, Luangtongkum T. The status of antimicrobial resistance in Campylobacter spp. isolated from animals and humans in Southeast Asia: A review. Thai J Vet Med 2020; 50(4):
451-458.
78. Aleksić E, Miljković-Selimović B, Tambur Z, Aleksić N, Biočanin V, Avramov S. Resistance to antibiotics in thermophilic campylobacters. Front Med (Lausanne) 2021; 8: 763434.
79. Centers for Disease Control and Prevention (CDC). National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Surveillance Report for 2014 (Final
Report). Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 2016. https://www.cdc.gov/narms/reports/annual-human-isolates-report-2014.html.
80. Wang Y, Zhang M, Deng F, et al. Emergence of multidrug-resistant Campylobacter species isolates with a horizontally acquired rRNA methylase. Antimicrob Agents Chemother 2014; 58(9):
5405-5412.
81. Chen JC, Tagg KA, Joung YJ, et al. Report of erm(B)+ Campylobacter jejuni in the United States. Antimicrob Agents Chemother 2018; 62(6): e02615-17.
82. Alter T, Reich F. Management strategies for prevention of Campylobacter infections through the poultry food chain: A European Perspective. In: Backert S, ed. Fighting Campylobacter Infec-
tions. Towards a One Health Approach. Switzerland, Springer; 2021.
83. Poly F, Noll AJ, Riddle MS, Porter CK. Update on Campylobacter vaccine development. Hum Vaccin Immunother 2019; 15(6): 1389-1400.
84. Quintel BK, Prongay K, Lewis AD, et al. Vaccine-mediated protection against Campylobacter-associated enteric disease. Sci Adv 2020; 6(26): eaba4511.